Skip to main content
. 2022 Mar 11;12:4295. doi: 10.1038/s41598-022-08346-2

Figure 1.

Figure 1

Comparison of the expression of CTSB in gliomas of different WHO grades, isocitrate dehydrogenase (IDH) status, 1p/19q-codeleted status and O6-methylguanine-DNA methyltransferase (MGMT) promoter status. CTSB was significantly highly-expressed in high-grade gliomas (HGG), IDH-wildtype, 1p19q non- codeletion and MGMT promoter unmethylation gliomas in TCGA and CGGA datasets. The expression of CTSB in TCGA dataset according to WHO grade (A), IDH status (overall WHO grades (C), LGG (E), HGG(G)), 1p/19q-codeleted status (I) and MGMT status (K). The expression of CTSB in CGGA dataset according to WHO grades (B) and IDH status (overall WHO grades (D), LGG (F), HGG(H)), 1p/19q-codeleted status (J) and MGMT status (L). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.